We are live on ! Find out more
FMTX

Forma Therapeutics Holdings, Inc. Common Stock

Delisted

FMTX was delisted on the 13th of October, 2022.

87 hedge funds and large institutions have $1.14B invested in Forma Therapeutics Holdings, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 49 increasing their positions, 17 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

188% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 17

63% more call options, than puts

Call options by funds: $686K | Put options by funds: $420K

12.59% more ownership

Funds ownership: 79.62%92.21% (+13%)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

6% less funds holding

Funds holding: 9387 (-6)

12% less capital invested

Capital invested by funds: $1.29B → $1.14B (-$154M)

46% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 13

Holders
87
Holders Change
-6
Holders Change %
-6.45%
% of All Funds
1.52%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.07%
New
7
Increased
49
Reduced
17
Closed
13
Calls
$686K
Puts
$420K
Net Calls
+$266K
Net Calls Change
+$266K

FMTX Hedge Fund Activity: Q1 2021 in Review

87 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Forma Therapeutics Holdings, Inc. Common Stock (FMTX) for Q1 2021, worth a combined $1.14B — down 12% from $1.29B a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of FMTX and 7 opened new positions — a net loss of 6 holders — while 17 trimmed existing stakes and 49 added.

The largest buyer was State Street, adding an estimated $36.7M. The largest seller was Wellington Management Group, cutting an estimated $40.6M.

  • 87 institutional investors held Forma Therapeutics Holdings, Inc. Common Stock (FMTX) as of Q1 2021, down from 93 in Q4 2020.
  • Funds reported $1.14B of Forma Therapeutics Holdings, Inc. Common Stock stock for Q1 2021, down 12% quarter-over-quarter.
  • 7 funds opened new Forma Therapeutics Holdings, Inc. Common Stock positions in Q1 2021 and 13 closed out, a net change of -6 holders.
  • The largest Forma Therapeutics Holdings, Inc. Common Stock buyer in Q1 2021 was State Street, an estimated $36.7M added.
  • The largest Forma Therapeutics Holdings, Inc. Common Stock seller in Q1 2021 was Wellington Management Group, an estimated $40.6M sold.

Based on aggregated 13F filings for Q1 2021.